Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $52.44 million versus the consensus estimate of $42.81 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.